Heparin dose for thrombosis prophylaxis during peripheral vascular angioplasty
Author:
Affiliation:
1. Maimonides Medical Center; Department of Internal Medicine; 4802 10th Avenue Brooklyn New York New York USA 11219
2. University of Connecticut; Department of Pulmonary Medicine; 24 Park Place Hartford Connecticut USA 06106
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008192/fullpdf
Reference5 articles.
1. Relation between procedural activated coagulation time and outcome after percutaneous transluminal angioplasty;Ferguson;Journal of the American College of Cardiology,1994
2. Assessment of heparin anticoagulation during peripheral angioplasty;Mulry;Journal of Vascular and Interventional Radiology,1991
3. Relation between activated clotting time during angioplasty and abrupt closure;Narins;Circulation,1996
4. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty;Rath;British Heart Journal,1990
5. In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant;Shammas;Journal of Invasive Cardiology,2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3